Physician profile
Sachin B Patel
NPI 1538116991
$6,861.04
in general payments reported to CMS, 2019-2025
39 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,124 · 2020: $209 · 2021: $654 · 2022: $1,065 · 2023: $1,218 · 2024: $1,269 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,745 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,744.87 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,283.97 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,018.06 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $571.72 | 2019-2025 | |
| Novo Nordisk INC | $517.99 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $490.92 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $399.24 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Gilead Sciences, INC. | $368.59 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $337.32 | 2022-2025 | Rexulti, Jynarque |
| Novartis Pharmaceuticals Corporation | $216.43 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.68 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.18 | 2021-2024 | |
| Shield Therapeutics INC | $119.45 | 2023-2024 | Accrufer |
| Janssen Pharmaceuticals, INC | $116.10 | 2019 | |
| Exact Sciences Corporation | $111.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $107.84 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.